Document is current
Any future updates will be listed below
-
Authors
Lindberg, Louise
Hassan Beck, Reem
Danielsson, Pernilla
Nielsen, Timmy
Abdalla, Asmahan
Ekstedt, Peter
Chaturvedi, Deepti
Al Qahtani, Nabras
Marcus, Claude
Deeb, Asma
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 31 August 2026
First Online: 10 September 2026
Declarations
Ethics approval and consent to participate: The study was conducted in accordance with the declaration of Helsinki and approved by the Institution Review Board of SSMC, Abu Dhabi (SSMCREC-395) as well as the Stockholm Ethics Committee (approval no. 2018/1413–31, amendment 2024-06085-02). The study is retrospectively registered on Clinicaltrials.gov (ID: NCT06665893) 2024-10-29.Eligible patients were invited to participate, after receiving both oral and written information from one of the study clinicians. Informed consent was obtained from the parents or legal guardians.
Consent for publication: Not applicable.
Competing interests: LL and TN are employees of, and have share rights in, Evira AB. CM is a board member and shareholder of Evira AB.
